Quadrivalent HPV vaccine snapped up by the public

Updated 2017-12-19 10:00:27 chinadaily.com.cn

The quadrivalent human papillomavirus (HPV) vaccine has enjoyed high popularity since it appeared on the market, Beijing Youth Daily reported.

It has won bidding in 11 provinces and municipalities at present, including Yunnan, Henan, Chongqing, Heilongjiang, Jiangxi, Hubei, Guangxi, Hunan, Sichuan, Fujian and Ningxia.

According to Chongqing Zhifei Biological Products, the exclusive agency of Merck & Co for the quadrivalent HPV vaccine, there exists a "vaccine buying spree" phenomenon due to tight supplies during the initial listing stage.

The number of people making appointments to get quadrivalent HPV vaccines within half a month has exceeded 27,700 in Changsha. The supply of vaccine is not adequate to meet the demand, so people have to wait in line by making appointments at many community health centers, and some have to wait until next year.

Conversely, few people show interest in the bivalent vaccine.

Having taken seven to eight years to complete clinical trials of the HPV vaccine, the bivalent and quadrivalent HPV vaccines eventually appeared on China's biopharmaceutical market.

Chongqing is the first city that brought the quadrivalent HPV vaccine into the market in China. Three doses of the HPV vaccine cost 2,856 yuan (0).

Some securities traders predict the scale of the vaccine market is expected to surpass 30 billion yuan.

Song Kai, chief analyst at the Huachuang Securities research institute, indicates that the market scale would run up to more than 20 billion yuan based on a hypothesis that 5 percent of women aged 20 to 45 are willing to get vaccinated.

The Zhongtai Securities research report is relatively more optimistic. It indicates that the market can be worth up to 32.3 billion yuan in terms of the prediction of a 5 percent penetration rate and 2,400 yuan for every three doses.

Cervical cancer is the first cancer that has a certain pathogeny, which is a persistent infection of the high-risk HPV virus. Getting an HPV vaccine is the most effective way of preventing an HPV infection and developing cervical cancer.

The US Centers for Disease Control and Prevention have been merely purchasing nine-valent HPV vaccine since April 2016. The bivalent and quadrivalent vaccines haven't been supplied since the end of 2016 in the United States.

Qiao Youlin, research director at the Chinese Academy of Medical Sciences of Cancer Epidemiology in Guangdong province, notes that the nine-valent vaccine has just obtained permission to develop clinical trials in China, but it would take less time for it to go on the market compared to bivalent and quadrivalent vaccines.

At present, people can get a nine-valent HPV vaccine in Hong Kong that costs approximately HK,000.

Also in the News

Nicole Kidman Recalls Oscar Glory: Loneliest Time
Showbiz2016/06/16 13:58June 19 2018 01:21:49

Nicole Kidman Recalls Oscar Glory: Loneliest Time

Attending Shanghai International Film Festival, Nicole Kidman talks about her role in "Grace of Monaco".

Labor Day Travel Peak Starts
Also in the News2014/05/01 12:16June 19 2018 01:21:49

Labor Day Travel Peak Starts

Johnny Depp Delivers a Speech 'Evolve the Future' in 'Transcendence'
Also in the News2014/04/18 13:18June 19 2018 01:21:49

Johnny Depp Delivers a Speech 'Evolve the Future' in 'Transcendence'

Hollywood star Johnny Depp's speech in the upcoming new film "Transcendence" has been disclosed on Friday, April 11th.

Most Watched

News:
China World Business Sports Showbiz Audio
Video:
C4 My Chinese Life The Sound Stage China Revealed Showbiz Video Travel Video
Photos:
China World Fun Travel Entertainment Sports
Travel:
Beijing Shanghai Guangzhou
Lifestyle:
Live Music Opera & Classical Movies Traditional Shows Exhibitions
Learn Chinese:
Chinese Studio Living Chinese Everyday Chinese Just For Fun Chinese Culture Buzzwords